Tectonic Therapeutic, Inc.
TECXNasdaqCIK 1681087HealthcareFiscal year ends Dec 31
Reports and events: 173 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-06-2016:25 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164480 |
| 2024-06-1811:51 ET | 8-K/A | 8.01 Other events | 0001193125-24-163207 |
| 2024-06-1416:30 ET | 8-K | 8.01 Other events | 0001193125-24-161663 |
| 2024-06-1116:29 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-159168 |
| 2024-06-0409:30 ET | 8-K | 8.01 Other events | 0001193125-24-153749 |
| 2024-05-0916:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057091 |
| 2024-03-1417:04 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031635 |
| 2024-01-3016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-019406 |
| 2024-01-3008:39 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-018812 |
| 2023-11-0916:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062131 |
| 2023-08-1016:32 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041408 |
| 2023-07-1207:13 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-034121 |
| 2023-06-1417:19 ET | 8-K/A | 2.05 Exit or disposal costs | 0001140361-23-029869 |
| 2023-06-1316:41 ET | 8-K | 8.01 Other events | 0001140361-23-029620 |
| 2023-06-1207:19 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-029221 |
| 2023-06-0916:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001140361-23-029124 |
| 2023-05-2207:04 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-025867 |
| 2023-05-1807:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-025377 |
| 2023-05-1116:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021318 |
| 2023-05-1107:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-024002 |
| 2023-05-0117:00 ET | DEF 14A | Proxy statementPeriod 2023-06-06 | 0000950170-23-016320 |
| 2023-05-0107:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-021828 |
| 2023-03-2316:34 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009527 |
| 2023-03-2307:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-013237 |
| 2023-02-2716:39 ET | 8-K | 8.01 Other events | 0001140361-23-008899 |
| 2022-12-0707:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-044662 |
| 2022-11-0816:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023269 |
| 2022-11-0807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-040396 |
| 2022-10-0716:26 ET | 8-K | 3.01 Delisting notice | 0001140361-22-036649 |
| 2022-08-0916:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016117 |
| 2022-08-0907:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-028807 |
| 2022-06-2916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-185087 |
| 2022-06-1016:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001564590-22-022999 |
| 2022-05-2407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-157956 |
| 2022-05-1808:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-153616 |
| 2022-05-1707:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-152426 |
| 2022-05-1016:32 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019306 |
| 2022-05-1007:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-145656 |
| 2022-04-2716:53 ET | DEF 14A | Proxy statementPeriod 2022-06-08 | 0001564590-22-016125 |
| 2022-03-1716:50 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-010895 |
| 2022-03-1707:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-077852 |
| 2022-02-0907:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-031820 |
| 2022-01-0716:21 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-22-004476 |
| 2022-01-0407:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-001034 |
| 2021-11-0416:43 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-054522 |
| 2021-11-0407:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-319324 |
| 2021-10-1907:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-301529 |
| 2021-08-0909:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-239966 |
| 2021-08-0517:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-041725 |
| 2021-08-0507:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-236976 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.